New hope for deadly brain tumors from skin cancer
NCT ID NCT02374242
Summary
This study is testing whether two immunotherapy drugs, nivolumab alone or nivolumab combined with ipilimumab, can help control melanoma that has spread to the brain. It enrolled 76 adults with these brain metastases. The goal is to see if these drugs, which help the immune system fight cancer, can shrink the brain tumors and improve survival for a condition with very few good treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Melanoma Institute Australia
Wollstonecraft, New South Wales, 2065, Australia
-
Peter MacCallum Cancer Centre
East Melbourne, Victoria, 3002, Australia
-
Princess Alexandra Hospital
Woolloongabba, Queensland, 4102, Australia
-
Royal Adelaide Hospital
Adelaide, South Australia, 5000, Australia
Conditions
Explore the condition pages connected to this study.